Douglas N. Durand
Founder at Durand Venture Associates LLC
Profile
Douglas N.
Durand is the founder of Durand Venture Associates LLC.
He is currently a Director at Oligomerix, Inc. Previously, he worked as a Director of Marketing & Regional Sales at Merck & Co., Inc., an Executive Director of Marketing at Astra Pharmaceuticals, Inc., and an Executive Director of Marketing at AstraZeneca Diagnostics.
Douglas N. Durand active positions
Companies | Position | Start |
---|---|---|
Oligomerix, Inc.
Oligomerix, Inc. Drugstore ChainsRetail Trade Oligomerix, Inc. develops novel therapeutics and diagnostic assays for alzheimer diseases. It is a biopharmaceutical company focused on the discovery and development of small molecule inhibitors, immunotherapeutic approaches and biomarkers targeting tau oligomers. The firm's platform is based on small neurotoxic aggregates of proteins such as tau oligomers, an important target for AD and other tauopathies characterized by the progressive accumulation of tau aggregates. The company was founded by James G. Moe, Eliot J. Davidowitz, Ishita Chatterjee and Pedro M. Rojas in 2006 and is headquartered in New York, NY. | Director/Board Member | - |
Durand Venture Associates LLC
Durand Venture Associates LLC Financial ConglomeratesFinance Durand Venture Associates LLC operates as a venture capital firm. The company was founded by Douglas N. Durand and is headquartered in Wilmington, DE. | Founder | - |
Former positions of Douglas N. Durand
Companies | Position | End |
---|---|---|
AstraZeneca Diagnostics | Sales & Marketing | - |
MERCK & CO., INC. | Sales & Marketing | - |
Astra Pharmaceuticals, Inc. | Sales & Marketing | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
MERCK & CO., INC. | Health Technology |
Private companies | 4 |
---|---|
Oligomerix, Inc.
Oligomerix, Inc. Drugstore ChainsRetail Trade Oligomerix, Inc. develops novel therapeutics and diagnostic assays for alzheimer diseases. It is a biopharmaceutical company focused on the discovery and development of small molecule inhibitors, immunotherapeutic approaches and biomarkers targeting tau oligomers. The firm's platform is based on small neurotoxic aggregates of proteins such as tau oligomers, an important target for AD and other tauopathies characterized by the progressive accumulation of tau aggregates. The company was founded by James G. Moe, Eliot J. Davidowitz, Ishita Chatterjee and Pedro M. Rojas in 2006 and is headquartered in New York, NY. | Retail Trade |
Astra Pharmaceuticals, Inc. | |
AstraZeneca Diagnostics | |
Durand Venture Associates LLC
Durand Venture Associates LLC Financial ConglomeratesFinance Durand Venture Associates LLC operates as a venture capital firm. The company was founded by Douglas N. Durand and is headquartered in Wilmington, DE. | Finance |
- Stock Market
- Insiders
- Douglas N. Durand